AI assistant
Sai Life Sciences Limited — Call Transcript 2026
Jan 28, 2026
61699_rns_2026-01-28_77ccfb9a-2cca-4537-9a88-bcb62e09b025.pdf
Call Transcript
Open in viewerOpens in your device viewer
28 January 2026
==> picture [147 x 35] intentionally omitted <==
| ToBSE LimitedPhiroze Jeejeebhoy Towers,Dalal Street, Mumbai – 400001Scrip Code- 544306 | ToNational Stock Exchange of India LimitedExchange Plaza, C-1, Block G, Bandra KurlaComplexBandra East, Mumbai – 400051Scrip Symbol– SAILIFE |
|---|
Sub: Intimation of schedule of Analyst / Institutional Investor Meeting.
Dear Sir/ Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company is hosting the Earnings Conference call on Friday, 6[th] February 2026 , at 04:00 PM (IST) for discussing Un-audited Financial Results of the Company for the Third Quarter and Nine Months ended 31 December, 2025.
Complete details of the earnings conference call are attached herewith for your reference.
We request you to take note of the same and oblige.
Thanking You,
For Sai Life Sciences Limited
RUNA Digitally signed by RUNA KARAN Date: 2026.01.28 KARAN 12:03:43 +05'30'
Runa Karan Company Secretary & Compliance Officer Membership No.: A13721
Encl.: As Above
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office
Registered office
Plot No. DS-7, IKP Knowledge Park, Turkapally (V), Shameerpet Mandal, Medchal-Malkajgiri (Dist), Hyderabad -500078, Telangana, India.
Contact us T: +91 40 6815 6000, F: +91 40 6815 6199 E: [email protected] W: www.sailife.com
L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Miyapur Road, Gachibowli, Hyderabad – 500032, Telangana, India.
==> picture [596 x 118] intentionally omitted <==
Sai Life Sciences Q3FY26 Results Conference Call At 4.00 pm IST on February 06, 2026 (Friday)
We are pleased to invite you to Sai Life Sciences Q3FY26 results conference call with the senior management. The conference call will be held on Friday, February 06, 2026, at 4:00 PM (IST). The call will be initiated with a brief management discussion on the earnings performance followed by an interactive Question & Answer session
The details of the earnings call are:
Date: February 06, 2026 | Time Slot (IST): 4:00 PM – 5:00 PM
Dial-in Number: +91 22 6280 1107, +91 22 7115 8008
Other Dial in Numbers :
International Toll Free: USA: 18667462133 | UK: 08081011573 | Singapore: 8001012045 |
Hong Kong: 800964448
Pre-Registration Facility for the call and dial in directly without waiting for the operator: Click Here
Or Copy this URL in your browser:
Management Representation from Sai Life Sciences Limited
Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer
Mr. Siva Chittor, Director and Chief Financial Officer
About Sai Life Sciences Limited
Sai Life Sciences is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with innovator pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new medicines. Headquartered in Hyderabad, India, with a strong global presence, the company offers integrated solutions spanning medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. Sai Life Sciences is committed to delivering high-quality, cost-effective, and scalable solutions while upholding the highest standards of safety, compliance, and integrity. With a focus on innovation and operational excellence, the company continues to strengthen its capabilities to support emerging therapeutic modalities and meet the evolving needs of the life sciences industry.
For more information, please visit www.sailife.com
For further information please contact: [email protected]
==> picture [594 x 13] intentionally omitted <==